Back to search
Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation trials you may qualify forThe purpose of this study is to determine the safety of alpelisib plus fulvestrant in men and post-menopausal women with HR-positive, HER2-negative, advanced or…
The goal of this observational study is to examine whether markers of PI3K pathway activation are associated with endocrine therapy response and clinicopatholog…